Revision of EU air quality laws in search of urgency and ambition: EFA at the 4th EU CleanAirForum
EFA travelled to Rotterdam (the Netherlands), to bring to the EU Clean Air Forum the perspective of allergy, asthma and COPD patients, at a crucial...
EFA responds to European Commission final consultations on the EU pharmaceutical legislation proposals
In November 2023, EFA responded to the European Commission final consultations on the much-awaited proposals for the revision of the EU general...
EU is scanning technologies for better Indoor Air Quality during pandemics
In November 2023, EFA participated in a full day workshop in Brussels to explore technologies for mitigating the transmission of airborne pathogens. At...
Health organisations urge EU member states to adopt their clean air negotiating position
In view of ongoing deliberations on the revision of the EU’s Ambient Air Quality Directive (AAQD), health organisations representing...
Capacity Building: First EFA sponsored advocates graduate as EUPATI Patients Experts
As part of the EFA Capacity Building 2022-2023, two EFA members completed the EUPATI Patient Expert Training Programme and graduated on the 26th of October...
Recording out! Webinar 'Sharing is Caring: Exchanging Knowledge on Asthma Care'
Watch the replay of our webinar and learn more about how information on asthma care can become more accessible. We presented a new educational...
EFA co-signs EADV Call to Action on chronic inflammatory skin disease
The European Academy for Dermatology and Venerology launched October 2023 a European call to action to drive positive change for chronic...
EFA calls on better care for atopic eczema patients at the EADV 2023
EFA presents highlights of the Atopic Eczema Consensus Europe Report at the EADV 2023 and calls on European policymakers to address the burden of atopic...
EFA organises the first SynAir-G workshop in Montpellier on the impact of indoor air pollutants on child health
EFA organises the first-ever SynAir-G hybrid workshop on the impact of indoor air pollutants on childhood health, highlighting the perspective of patients...
TOLIFE: mission and achievements of the Patient Advisory Group (PAG) in the first year of the project
EFA joins TOLIFE partners in Barcelona to celebrate the first year of the project, highlighting important milestones of the Patient Advisory Group...
EFA submits respiratory patients’ considerations to ECHA draft restriction on PFAS
Source: European Chemicals Agency (ECHA)
This week EFA participated in the European Chemicals Agency (ECHA) consultation on the proposal for the restriction...
PRESS RELEASE - World Lung Day: AboutAsthma.org website launched to help asthma patients in Europe
Brussels, 25 September 2023 (World Lung Day) – A new website, AboutAsthma.org, was launched today by the European Federation of Allergy and Airways...
The European Parliament adopts an ambitious position for the revision of air quality laws
On Wednesday 13 September the European Parliament plenary held a key vote on the revision EU Air Quality rules. Despite the delicate balances within the...
World Atopic Eczema Day 2023: EFA mobilises the European community to join the #IfYouOnlyKnew campaign and embrace young patients’ needs
On September 14th, patient communities in Europe joined forces for the 6th World Atopic Eczema Day to raise awareness of the burden of Atopic Eczema. Watch...
PRESS RELEASE - World Atopic Eczema Day 2023: #ifyouonlyknew the burdens on children and youth living with AE
Patient communities join forces to empower their youngest members and their carers
On September 14th, World Atopic Eczema Day, patient communities across...
World Atopic Eczema Day 2023: #IfYouOnlyKnew the burdens on children and youth living with Atopic Eczema
On September 14th, World Atopic Eczema Day, patient communities across the globe join forces to raise awareness on the psychosocial burden of children...
3TR project: Severe asthma core outcomes published!
We are happy to announce that EFA is a co-author in one of the most recent publications of 3TR – COMSA.
As part of the 3TR project, EFA works closely...
EFA appointed to the Health Technology Assessment (HTA) Stakeholder Network
EFA is delighted to have been selected as a member of the newly-established European Commission’s Health Technology Assessment (HTA) Stakeholder Network,...
EFA at the EAACI Congress 2023
From the 9th to the 11th of June EFA representatives attended the annual congress of the European Academy of Allergy and Clinical Immunology (EAACI)...
AI in healthcare: EFA explores opportunities and new threats for allergy and respiratory patient associations at EPF bootcamp
Innovation is pacing faster than ever, and Artificial Intelligence (AI) and its applications have already entered our lives. The healthcare sector...